Cargando…
Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor
Head and neck (HN) cancer is an endemic disease in Taiwan, China. Locally recurrent HN cancer after full-dose irradiation poses a therapeutic challenge, and boron neutron capture therapy (BNCT) may be a solution that could provide durable local control with tolerable toxicity. The Tsing-Hua Open Poo...
Autores principales: | Wang, Ling-Wei, Liu, Yen-Wan Hsueh, Chou, Fong-In, Jiang, Shiang-Huei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006853/ https://www.ncbi.nlm.nih.gov/pubmed/29914577 http://dx.doi.org/10.1186/s40880-018-0295-y |
Ejemplares similares
-
Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer
por: Suzuki, Minoru, et al.
Publicado: (2014) -
Designation Products: Boron Neutron Capture Therapy for Head and Neck Carcinoma
por: Kanno, Hitoshi, et al.
Publicado: (2021) -
A comparison of dose distributions in gross tumor volume between boron neutron capture therapy alone and combined boron neutron capture therapy plus intensity modulation radiation therapy for head and neck cancer
por: Lee, Jia-Cheng, et al.
Publicado: (2019) -
Improvement in the neutron beam collimation for application in boron neutron capture therapy of the head and neck region
por: Hu, Naonori, et al.
Publicado: (2022) -
Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer
por: Barth, Rolf F, et al.
Publicado: (2012)